Login | Register
IAM Life Sciences: Key issues for senior life sciences executives 2022
IAM Life Sciences: Key issues for senior life sciences executives 2022

Key analysis designed to help senior life sciences executives better understand the strategic and legal IP challenges that they face around the world, so as to help them protect, enforce and monetise the IP rights that are so crucial to businesses in the space.

Articles

Why brand-name pharmaceuticals should look to China’s patent linkage system

Juhua Luo and Yingying Chen
CCPIT Patent and Trademark Law Office

Tips and tricks on how to obtain patent protection for polymorphs

Arwed Burrichter, Natalie Kirchhofer and Melanie Lödige
COHAUSZ & FLORACK

Protecting second medical use inventions in Europe

Markus Grammel and Elena Biselli
Grünecker Patent Attorneys and Attorneys-at-Law

Written description: a death knell to genus claims in biotechnology

Brian M Gummow, Alison Care, Karen Mangasarian and James F Haley Jr
Haley Guiliano LLP

Winning IP strategies for small and medium-sized biotechs

Manisha Singh and Shikha Singh
LexOrbis

From academy to industry: China’s new trend and policies on academic technology transfer

Yuan Zhang and Zongliang (Stephen) Zou
Liu Shen & Associates

How to successfully protect antibodies at the EPO

Caroline Pallard
NLO

Legal and strategic questions surrounding biologic and biosimilar litigation

Karla Olvera and Ingrid Ortiz
OLIVARES

Unified Patent Court: an introduction for life sciences companies

Emmanuel Gougé, Marc Holtorf and Sarah Taylor
Pinsent Masons

Unified Patent Court: strategic considerations for life sciences companies

András Kupecz, Ann Henry and Sarah Taylor
Pinsent Masons

Unlock unlimited access to all IAM content

Subscribe Now